DASH vs KRMD · P/E 76, rev $13.72B vs rev $33.6M
DoorDash, Inc. Class A Common Stock (DASH) versus Repro Med Systems Inc (KRMD) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Repro Med Systems Inc (KRMD) is a medical instruments & supplies company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported KRMD revenue for 2024-12-31 was $33.6M. Net income was -$6.1M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. KRMD currently screens at market cap $186.0M.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. KRMD currently screens at market cap $186.0M.
Not investment advice. Open the DASH and KRMD stock pages for the full models.
Not investment advice.